Medical Equipment

Projected Growth of the Global Cancer Diagnostics Market to Reach $40.07 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cancer diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Cancer Diagnostics Market By The End Of 2029?

The cancer diagnostics market has demonstrated robust expansion in recent years. It is projected to increase from $23.24 billion in 2024 to $25.5 billion in 2025, maintaining a compound annual growth rate (CAGR) of 9.7%. Historically, this growth can be attributed to increasing cancer incidence, cancer screening programs, personalized medicine, and public awareness.

The cancer diagnostics market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $40.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.0%. This expansion during the projection period stems from factors such as the development of emerging markets, governmental backing, the integration of artificial intelligence (ai) and machine learning, and advancements in early detection and intervention. Key developments expected within this period encompass liquid biopsies, multi-omics methodologies, point-of-care testing, and initiatives focused on screening and early intervention.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

Which Business Drivers Are Underpinning The Growth Of The Cancer Diagnostics Market?

The significant occurrence of various cancer types acts as a primary catalyst for the cancer diagnostics market. This is attributed to the increasing incidence rates of different cancers, which compels more individuals to pursue diagnosis and treatment. Moreover, the World Health Organization (WHO) reported cancer as the second-leading cause of death globally. The National Cancer Institute (NCI) forecasts that the annual count of new cancer cases will reach 23.6 million by 2030.

What Are The Principal Segment Types In The Cancer Diagnostics Market?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Which Long-Term Trends Will Play A Crucial Role In The Cancer Diagnostics Market?

AI-powered cancer detection systems are gaining prominence as an emerging trend in the cancer diagnostics market. AI assists in enhancing the precision of image analysis within diagnostic procedures for conditions such as breast cancer and lung cancer, facilitating earlier detection. Moreover, AI contributes to reducing the occurrence of false positives in lung cancer screening, thereby improving lung cancer detection accuracy. For example, researchers at the Naval Medical Center San Diego and Google AI, Google’s AI research division, developed a robust solution featuring cancer-detecting algorithms for autonomous evaluation of lymph node biopsies. This AI solution successfully elevated the accuracy of metastatic breast cancer detection to 99%.

Which Companies Are Contributing Significantly To The Cancer Diagnostics Market Growth?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Region Offers The Most Opportunity For Cancer Diagnostics Market Expansion?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Browse Through More Reports Similar to the Global Cancer Diagnostics Market 2025, By The Business Research Company

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795